We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.01M
2
XOM icon
ExxonMobil
XOM
+$802K
3
HCA icon
HCA Healthcare
HCA
+$801K
4
MRO
Marathon Oil Corporation
MRO
+$634K
5
AMGN icon
Amgen
AMGN
+$604K

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FULC icon
3376
Fulcrum Therapeutics
FULC
$297M
– –
-198
Closed -$707
GBIO
3377
DELISTED
Generation Bio
GBIO
– –
-5
Closed -$124
GTN icon
3378
Gray Television
GTN
$552M
– –
-170
Closed -$911
HOUS
3379
DELISTED
Anywhere Real Estate
HOUS
– –
-29
Closed -$147
HPP
3380
Hudson Pacific Properties
HPP
$779M
– –
-900
Closed -$30.1K
ILF icon
3381
iShares Latin America 40 ETF
ILF
$3.83B
– –
-190
Closed -$4.92K
INO icon
3382
Inovio Pharmaceuticals
INO
$69M
– –
-24
Closed -$139
INZY
3383
DELISTED
Inozyme Pharma
INZY
– –
-27
Closed -$141
IPSC icon
3384
Century Therapeutics
IPSC
$361M
– –
-131
Closed -$224
IRWD icon
3385
Ironwood Pharmaceuticals
IRWD
$714M
– –
-6,170
Closed -$25.4K
LESL icon
3386
Leslie's
LESL
$11M
– –
-6
Closed -$382
LEVI icon
3387
Levi Strauss
LEVI
$9.39B
– –
-1,010
Closed -$22K
LNZA icon
3388
LanzaTech
LNZA
$69.8M
– –
-10
Closed -$1.81K
LRMR icon
3389
Larimar Therapeutics
LRMR
$432M
– –
-44
Closed -$288
MGNX icon
3390
MacroGenics
MGNX
$257M
– –
-190
Closed -$625
NKTX icon
3391
Nkarta
NKTX
$172M
– –
-9,972
Closed -$45.1K
OPRX icon
3392
OptimizeRx
OPRX
$133M
– –
-266
Closed -$2.05K
OTEX icon
3393
Open Text
OTEX
$6.04B
– –
-13
Closed -$433
OTLY
3394
Oatly Group
OTLY
$438M
– –
-46
Closed -$794
OTLK icon
3395
Outlook Therapeutics
OTLK
$191M
– –
-982
Closed -$5.24K
PRME icon
3396
Prime Medicine
PRME
$559M
– –
-654
Closed -$2.53K
RCI icon
3397
Rogers Communications
RCI
$18.6B
– –
-3
Closed -$121
REI icon
3398
Ring Energy
REI
$339M
– –
-346
Closed -$554
RLAY icon
3399
Relay Therapeutics
RLAY
$4.33B
– –
-184
Closed -$1.3K
SANA icon
3400
Sana Biotechnology
SANA
$980M
– –
-88
Closed -$366
134 135
136
137 138

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
HC
Henshaw Capital Woburn, Massachusetts $2.7B AUM 29.67% 1-Year Est. Return
CI
Capital International Los Angeles, California $2.7B AUM 31.08% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.